Literature DB >> 16815591

Outbreak of Acinetobacter genomic species 3 in a Dutch intensive care unit.

D Idzenga, M A Schouten, A R H van Zanten.   

Abstract

Mesh：

Year:  2006        PMID： 16815591     DOI： 10.1016/j.jhin.2006.03.014

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


× No keyword cloud information.
  9 in total

1.  A case of IMP-4-, OXA-421-, OXA-96-, and CARB-2-producing Acinetobacter pittii sequence type 119 in Australia.

Authors:  Witchuda Kamolvit; Petra Derrington; David L Paterson; Hanna E Sidjabat
Journal:  J Clin Microbiol       Date:  2014-11-26       Impact factor: 5.948

2.  Clinical features of infections and colonization by Acinetobacter genospecies 3.

Authors:  José Molina; José Miguel Cisneros; Felipe Fernández-Cuenca; Jesús Rodríguez-Baño; Anna Ribera; Alejandro Beceiro; Luis Martínez-Martínez; Álvaro Pascual; Germán Bou; Jordi Vila; Jerónimo Pachón
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

3.  Comparison of genospecies and antimicrobial resistance profiles of isolates in the Acinetobacter calcoaceticus-Acinetobacter baumannii complex from various clinical specimens.

Authors:  Ni Tien; Bang-Jau You; Hui-Lan Chang; Hsiu-Shen Lin; Chin-Yi Lee; Tung-Ching Chung; Jang-Jih Lu; Chao-Chin Chang
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

4.  OXA-207, a novel OXA-24 variant with reduced catalytic efficiency against carbapenems in Acinetobacter pittii from Spain.

Authors:  Rodrigo Cayô; María Merino; Belén Ruiz Del Castillo; María Eliecer Cano; Jorge Calvo; Germán Bou; Luis Martínez-Martínez
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

5.  Molecular characterisation and control of Acinetobacter baumannii isolates resistant to multi-drugs emerging in inter-intensive care units.

Authors:  Ayşe Ertürk; Ayşegül Çopur Çiçek; Aziz Gümüş; Erkan Cüre; Ahmet Şen; Aysel Kurt; Alper Karagöz; Nebahat Aydoğan; Cemal Sandallı; Rıza Durmaz
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-07-22       Impact factor: 3.944

Review 6.  The Acinetobacter baumannii group: a systemic review.

Authors:  Hua-Zhong Zhang; Jin-Song Zhang; Li Qiao
Journal:  World J Emerg Med       Date:  2013

Review 7.  Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections.

Authors:  Uh Jin Kim; Hee Kyung Kim; Joon Hwan An; Soo Kyung Cho; Kyung-Hwa Park; Hee-Chang Jang
Journal:  Chonnam Med J       Date:  2014-08-20

8.  Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center.

Authors:  Daniel De Vos; Jean-Paul Pirnay; Florence Bilocq; Serge Jennes; Gilbert Verbeken; Thomas Rose; Elkana Keersebilck; Petra Bosmans; Thierry Pieters; Mony Hing; Walter Heuninckx; Frank De Pauw; Patrick Soentjens; Maia Merabishvili; Pieter Deschaght; Mario Vaneechoutte; Pierre Bogaerts; Youri Glupczynski; Bruno Pot; Tanny J van der Reijden; Lenie Dijkshoorn
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

9.  Identification of Acinetobacter Species Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.

Authors:  Seri Jeong; Jun Sung Hong; Jung Ok Kim; Keon Han Kim; Woonhyoung Lee; Il Kwon Bae; Kyungwon Lee; Seok Hoon Jeong
Journal:  Ann Lab Med       Date:  2016-07       Impact factor: 3.464
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.